Neftaly: Merck Inc.

Introduction

Merck & Co., Inc., commonly known as Merck in the United States and Canada, is a global healthcare company renowned for its research-driven approach to developing innovative medicines, vaccines, and animal health products. Founded in 1891, Merck has played a vital role in advancing medical science and improving patient outcomes worldwide.

---

Company Overview

• Founded: 1891 (as the American affiliate of the German Merck family company)
• Headquarters: Kenilworth, New Jersey, USA
• Industry: Pharmaceuticals, Biotechnology, Animal Health
• Employees: Approximately 68,000 (as of recent data)
• Global Reach: Operates in over 140 countries

---

Core Areas of Focus

• Human Health: Merck develops prescription medicines and vaccines addressing areas such as oncology, infectious diseases, diabetes, and cardiovascular health.
• Animal Health: The company offers products and services for livestock, pets, and aquaculture to improve animal well-being and productivity.
• Research & Development: Merck invests billions annually in R&D, focusing on cutting-edge therapies like immuno-oncology, vaccines, and novel antiviral drugs.

---

Notable Achievements

• Development of the HPV vaccine Gardasil, a breakthrough in preventing cervical cancer.
• Contributions to HIV/AIDS treatment with antiretroviral therapies.
• Pioneering cancer immunotherapy drugs such as Keytruda, which has revolutionized treatment for several cancer types.

---

Corporate Responsibility

Merck is committed to global health initiatives, access to medicines, and sustainable business practices. The company collaborates with governments, NGOs, and health organizations to address public health challenges worldwide.

---

Conclusion

Merck Inc. stands as a leader in the pharmaceutical industry, combining scientific innovation with a mission to improve lives. Neftaly highlights Merck’s impact on healthcare and its ongoing pursuit of medical breakthroughs.